Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
The CVS Health stock price rebounded to $48 on Monday, up 10% from its lowest in December. This rebound continued after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback